Suntrust Banks’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Suntrust Banks’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,000	Closed	-$34K	–	1926
2014 Q1	$34K	Hold	1,000	–	–	﹤0.01%	1885
2013 Q4	$19K	Hold	1,000	–	–	﹤0.01%	1829
2013 Q3	$16K	Buy	+1,000	New	+$11.6K	﹤0.01%	1823

Other funds holding CTIC

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Suntrust Banks's CTIC Position: Q2 2014 in Review

Suntrust Banks sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2014, closing a stake of 1,000 shares — an estimated $34K sold.

Suntrust Banks first reported a position in CTIC in Q3 2013 and held it in 3 quarters. The position peaked at $34K in Q1 2014. 89 funds tracked by Wall St. Rank hold CTIC as of Q2 2014.

Suntrust Banks reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2014 after selling out during the quarter.
Suntrust Banks sold 1,000 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2014, an estimated $34K.
Suntrust Banks first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2013 and held it in 3 quarters.
Suntrust Banks's CTI BioPharma Corp. (DE) Common Stock position peaked at $34K in Q1 2014.
89 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2014.

Based on Suntrust Banks's 13F filing for Q2 2014, filed 14 Aug 2014.